UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
JW subsidiaries team up to sell J&J’s hair loss treatment
JW Shinyak said Thursday that it has entered a joint sales agreement with J...
by Lee Han-soo
|
2018-03-29 17:12
라인
Dongkoo Bio inks deal to sell OTC prostate drug
Dongkoo Bio & Pharma said it has signed a licensing-in deal with Swedish dr...
by So Jae-hyeon
|
2018-03-29 14:18
라인
Hanmi adds smart plant to Paltan complex
Hanmi Pharmaceutical said Thursday that it added an eight-story information...
by Marian Chu
|
2018-03-29 13:04
라인
Hanmi wins nod to test antihypertensive cocktail of 4 drugs
Hanmi Pharmaceutical has obtained approval to test a combination therapy of...
by Lee Hye-seon
|
2018-03-28 17:19
라인
Invossa’s encouraging trial results presented in US
Invossa, gene therapy for osteoarthritis of the knee, has shown promising r...
by Nam Doo-hyun
|
2018-03-28 15:05
라인
Drugmakers step up anti-fine dust marketing
Pharmaceutical companies are focusing their marketing activities on fightin...
by So Jae-hyeon
|
2018-03-28 11:35
라인
Prescriptions of anticancer drugs surged in January
Prescriptions of anticancer drugs surged in January compared to a year earl...
by Nam Doo-hyun
|
2018-03-27 14:14
라인
Seoul OKs plan to test systemic sclerosis drug Lenabasum
The pharmaceutical industry is paying attention to whether Lenabasum, an in...
by Lee Hye-seon
|
2018-03-27 11:36
라인
Opdivo adds gastric cancer to indications
Bristol-Myers Squibb Korea Pharmaceutical and Ono Pharma Korea said their c...
by Nam Doo-hyun
|
2018-03-27 11:34
라인
Drugmakers seek partners to boost diabetes business
Pharmaceutical companies are seeking new partners to boost drug sales in th...
by So Jae-hyeon
|
2018-03-26 12:33
라인
Pharmicell aims to test dendritic cell-based cancer drug this year
A local stem cell developer has raised a possibility that dendritic cells m...
by So Jae-hyeon
|
2018-03-23 16:41
라인
Local drugmakers poor at winning nod for clinical trials
Samsung Medical Center obtained the most approvals for clinical trials in t...
by Lee Hye-seon
|
2018-03-23 12:04
라인
Anticoagulant latecomer Lixiana outrivals Eliquis
The competition between No.2 and No.3 next-generation anticoagulant is heat...
by So Jae-hyeon
|
2018-03-22 16:12
라인
Yuyu to start clinical trials on dry eye treatment
Yuyu Pharmaceuticals said Thursday that it has received approval from the M...
by Lee Han-soo
|
2018-03-22 14:34
라인
Daewoong to promote AstraZeneca’s diabetes treatment
Daewoong Pharmaceutical and AstraZeneca Korea have signed a co-promotion pa...
by Lee Han-soo
|
2018-03-22 11:25
라인
Daiichi Sankyo Korea to co-market Kuhnil’s dyslipidemia treatment
Daiichi Sankyo Korea said Thursday that it has signed a strategic partnersh...
by Lee Han-soo
|
2018-03-22 11:25
라인
European urology group praises Gemvax & KAEL’s research paper
Gemvax & KAEL said Wednesday that the European Association of Urology (EAU)...
by Lee Han-soo
|
2018-03-22 11:24
라인
Roche’s Tecentriq gets reimbursement as 2nd line treatment for 2 cancers
Roche Korea (CEO: Matt Sause) said Wednesday that the country’s first anti ...
by Marian Chu
|
2018-03-21 18:27
라인
JW Pharma gets orphan drug status for Roche’s hemophilia treatment
JW Pharmaceutical said Wednesday that the Ministry of Food and Drug Safety ...
by Lee Han-soo
|
2018-03-21 15:47
라인
Daewoong promotes botulinum toxin Nabota in Dubai
Daewoong Pharmaceutical has begun pushing international marketing activitie...
by So Jae-hyeon
|
2018-03-21 15:47
-
이전
91
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top